Influencing Factors of Cerebrovascular Disease and Cognition in Hemodialysis Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age50-85
SponsorHuashan Hospital
About this trial
In this observational study, the investigators evaluate the influencing factors of cerebrovascular disease and cognition in hemodialysis patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
maintenance hemodialysis patients who are younger than 85 years old and older than 50 years old, regardless of gender
dialysis vintage is greater than 3 months;
Disqualifiers
Those with severe infection and anemia (Hb <60g / L);
Those with severe mental illness, metabolic diseases and immune system diseases;
Patients with abnormal liver function
Trial population
maintenance hemodialysis patients
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
cerebrovascular disease
Magnetic resonance images will be used to determine the severity of white matter hyperintensity, using the Scheltens scale. Score 2 or more is abnormal.
Time frame
5 yearsSecondary outcomes
1
changes in cognitive function
The Mini-Mental State Examination (MMSE) will be used to assess the changes in cognitive function.The MMSE has a maximum score of 30 points. The scores are generally grouped as follows: 25-30 points: normal cognition 21-24 points: mild dementia 10-20 points: moderate dementia 9 points or lower: severe dementiaThe Mini-Mental State Examination (MMSE) will be used to assess the changes in cognitive function.The MMSE has a maximum score of 30 points. The scores are generally grouped as follows: 25-30 points: normal cognition 21-24 points: mild dementia 10-20 points: moderate dementia 9 points or lower: severe dementia
Time frame
5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov